Matzim LA 360mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely.
Take your medication as directed by your doctor, swallowing the tablets whole without chewing, breaking, or crushing them.
Establish a routine by taking your medication at the same time every day.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start feeling well.
Storing and Disposing of Your Medication
To maintain the effectiveness and safety of your medication:
Store it at room temperature, protected from light and moisture.
Keep it in a dry place, avoiding storage in a bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
* Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist. Check with your pharmacist for guidance on the best disposal method, and consider participating in local drug take-back programs.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Avoid taking two doses at the same time or taking extra doses.
Lifestyle & Tips
- Take the medication exactly as prescribed, usually once daily. Do not crush, chew, or break the extended-release tablet.
- Swallow the tablet whole with a glass of water.
- Maintain a healthy diet, low in sodium and saturated fats.
- Engage in regular physical activity as advised by your doctor.
- Limit alcohol intake.
- Avoid sudden changes in position (e.g., standing up quickly) to prevent dizziness.
- Inform your doctor about all other medications, supplements, and herbal products you are taking.
- Do not stop taking this medication suddenly without consulting your doctor, as it can worsen your condition.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Severe dizziness or fainting
Slow heartbeat
New or worsening abnormal heartbeat
Worsening heart failure (if you have a history of heart failure, discuss this with your doctor). Seek immediate medical attention if you experience:
+ Shortness of breath
+ Sudden weight gain
+ Swelling in the arms or legs
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other severe skin reactions, which can be life-threatening. Seek medical help right away if you notice:
+ Red, swollen, blistered, or peeling skin
+ Other skin irritation (with or without fever)
+ Red or irritated eyes
+ Sores in your mouth, throat, nose, or eyes
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you are bothered by any of the following side effects or if they do not go away, contact your doctor or seek medical attention:
Headache
* Feeling dizzy, tired, or weak
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or lightheadedness, especially when standing up.
- Fainting spells.
- Unusual swelling in your ankles, feet, or hands.
- Shortness of breath or difficulty breathing, especially at rest or with mild exertion.
- Very slow heart rate (e.g., less than 50 beats per minute).
- New or worsening chest pain.
- Signs of liver problems (e.g., yellowing of skin/eyes, dark urine, persistent nausea/vomiting, severe stomach pain).
- Severe skin rash or allergic reaction.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain types of abnormal heart rhythms, as this medication is not suitable for use with some arrhythmias. If you are unsure, consult your doctor or pharmacist for guidance.
Existing health conditions, such as:
+ Fluid accumulation in the lungs
+ Low blood pressure
+ Recent heart attack
Current medications, including:
+ Ivabradine
+ Rifampin
* All other prescription and over-the-counter (OTC) medications, natural products, and vitamins you are taking, as this is not an exhaustive list of potential interactions.
To ensure safe use, it is crucial to discuss all your medications and health conditions with your doctor and pharmacist. Do not initiate, discontinue, or modify the dosage of any medication without first consulting your doctor to confirm it is safe to do so.
Precautions & Cautions
When starting this medication, be cautious when performing tasks that require your full attention, such as driving, until you understand how it affects you. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying down position, and exercise care when climbing stairs.
As directed by your doctor, regularly monitor your blood pressure and heart rate. You may need to undergo an electrocardiogram (ECG) before initiating treatment with this medication and at intervals during treatment. Discuss any concerns or questions with your doctor.
If you have high blood pressure and are taking this medication, consult your doctor before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids.
Additionally, if you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. It is also recommended that you talk to your doctor before consuming alcohol while taking this medication.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
It is crucial to inform your doctor if you are pregnant, planning to become pregnant, or are breastfeeding. You and your doctor will need to discuss the potential benefits and risks of this medication to both you and your baby.
Overdose Information
Overdose Symptoms:
- Severe hypotension (very low blood pressure)
- Profound bradycardia (extremely slow heart rate)
- High-degree atrioventricular (AV) block
- Cardiogenic shock
- Asystole (cardiac arrest)
- Metabolic acidosis
- Hyperglycemia
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive and may include IV fluids, vasopressors (e.g., norepinephrine), atropine, calcium gluconate/chloride, glucagon, and cardiac pacing.
Drug Interactions
Contraindicated Interactions
- Ivabradine (risk of severe bradycardia)
- Dantrolene (IV) (risk of cardiovascular collapse)
Major Interactions
- Beta-blockers (additive negative chronotropic and inotropic effects, risk of bradycardia, AV block, heart failure)
- Digoxin (increased digoxin levels, risk of toxicity)
- Statins (e.g., Simvastatin, Lovastatin - increased statin levels, risk of myopathy/rhabdomyolysis due to CYP3A4 inhibition)
- Amiodarone (risk of severe bradycardia, AV block, hypotension)
- Fentanyl (risk of severe bradycardia, hypotension)
- Midazolam, Triazolam (increased benzodiazepine levels due to CYP3A4 inhibition)
- Cyclosporine, Tacrolimus, Sirolimus (increased immunosuppressant levels)
- Carbamazepine, Phenytoin (increased anticonvulsant levels)
- Alpha-blockers (e.g., Prazosin, Doxazosin - risk of severe hypotension)
- Clonidine (risk of severe bradycardia, AV block)
Moderate Interactions
- Other antihypertensives (additive hypotensive effects)
- Grapefruit juice (may increase diltiazem levels)
- Cimetidine (may increase diltiazem levels)
- Rifampin (may decrease diltiazem levels)
- Theophylline (increased theophylline levels)
- Buspirone (increased buspirone levels)
Minor Interactions
- Not typically clinically significant interactions for minor category.
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide initial dosing for hypertension/angina.
Timing: Prior to initiation.
Rationale: To establish baseline and assess for bradycardia, especially with other rate-lowering drugs.
Timing: Prior to initiation.
Rationale: To assess for pre-existing conduction abnormalities (e.g., AV block) and PR interval.
Timing: Prior to initiation, especially in patients with cardiac history.
Rationale: Diltiazem is extensively metabolized by the liver; baseline assessment is important.
Timing: Prior to initiation.
Rationale: To assess kidney function, though renal elimination is minor, severe impairment requires caution.
Timing: Prior to initiation.
Routine Monitoring
Frequency: Regularly, especially during dose titration and periodically thereafter (e.g., weekly during titration, then monthly/quarterly).
Target: <130/80 mmHg (or individualized target)
Action Threshold: Persistent hypotension (<90/60 mmHg) or uncontrolled hypertension.
Frequency: Regularly, especially during dose titration and periodically thereafter (e.g., weekly during titration, then monthly/quarterly).
Target: 50-90 bpm (or individualized target)
Action Threshold: Bradycardia (<50 bpm) or symptomatic bradycardia.
Frequency: Periodically, especially if dose is increased or if patient develops symptoms of conduction disturbance or is on other AV nodal blocking agents.
Target: PR interval <0.20 seconds
Action Threshold: Significant PR prolongation (>0.24 seconds) or development of higher-degree AV block.
Frequency: At each visit.
Target: Absence of significant edema.
Action Threshold: Development of new or worsening peripheral edema.
Symptom Monitoring
- Dizziness
- Lightheadedness
- Fatigue
- Headache
- Peripheral edema (swelling of ankles/feet)
- Shortness of breath
- Chest pain (for angina management)
- Palpitations
- Bradycardia (slow heart rate)
Special Patient Groups
Pregnancy
Diltiazem is Pregnancy Category C. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown adverse effects, but there are no adequate and well-controlled studies in pregnant women.
Trimester-Specific Risks:
Lactation
Diltiazem is excreted in breast milk. The American Academy of Pediatrics considers it compatible with breastfeeding, but caution is advised. Monitor the infant for bradycardia, hypotension, and sedation.
Pediatric Use
Safety and efficacy have not been established in pediatric patients. Use is generally not recommended.
Geriatric Use
Geriatric patients may be more sensitive to the effects of diltiazem, particularly regarding hypotension and bradycardia. Initiate therapy at the lower end of the dosing range and titrate slowly with close monitoring of blood pressure and heart rate due to potential for decreased hepatic and renal function and polypharmacy.
Clinical Information
Clinical Pearls
- Matzim LA is an extended-release formulation designed for once-daily dosing. Emphasize to patients not to crush, chew, or break the tablets.
- Monitor heart rate and blood pressure regularly, especially during initial titration and when combining with other rate-lowering agents (e.g., beta-blockers).
- Diltiazem is a CYP3A4 inhibitor; be mindful of potential drug interactions with substrates of this enzyme (e.g., statins, immunosuppressants, digoxin).
- Peripheral edema is a common side effect, usually dose-dependent and often manageable. Differentiate from heart failure symptoms.
- Patients should be advised to report any signs of severe bradycardia, dizziness, or worsening heart failure symptoms immediately.
- While generally well-tolerated, caution is warranted in patients with sick sinus syndrome, second- or third-degree AV block (without a pacemaker), or severe hypotension.
Alternative Therapies
- Other calcium channel blockers (e.g., Amlodipine, Felodipine, Verapamil)
- ACE inhibitors (e.g., Lisinopril, Enalapril)
- Angiotensin Receptor Blockers (ARBs) (e.g., Valsartan, Losartan)
- Beta-blockers (e.g., Metoprolol, Atenolol)
- Diuretics (e.g., Hydrochlorothiazide, Furosemide)
- Alpha-1 blockers (e.g., Prazosin, Doxazosin)